Abstract
Six peptidyl organotrifluoroborates and their corresponding boronate esters and/or boronic acid analogs were designed and synthesized. Their anti-proliferative activity against hepatocellular carcinoma cells (HepG2) and human metastatic breast cancer cells (MDA-MB231) were evaluated by use of an MTT assay. Potassium {4-[(3S,6S,9S)-3,6-dibenzyl-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}trifluoroborate (B6) was potent (IC50 = 29.9 μM) against MDA-MB231, and {4-[(3S,6S,9S)-6-benzyl-3-((benzyloxy)methyl)-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}boronic acid (B9) and Potassium {4-[(3S,6S,9S)-6-benzyl-3-((benzyloxy)methyl)-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}trifluoroborate (B10) had broad anti-proliferative activity against HepG2 (IC50 = 24.7 and 21.8 μM, respectively) and MDA-MB231 (IC50 = 24.5 and 18.9 μM, respectively).
Similar content being viewed by others
References
N. Miyaura, A. Suzuki, Chem. Rev. 95, 2457 (1995)
R. Smoum, A. Rubinstein, M. Srebnik, Org. Biomol. Chem. 3, 941 (2005)
R.A. Oliveira, L. Savegnago, C.R. Jesse, P.H. Menezes, G.A. Molander, C.W. Nogueira, Basic Clin. Pharmacol. Toxicol. 104, 448 (2009)
T. Mosmann, J. Immunol. Methods 65, 55 (1983)
G.A. Molander, L.N. Cavalcanti, B. Canturk, P.-S. Pan, L.E. Kennedy, J. Org. Chem. 74, 7364 (2009)
G.A. Molander, D.J. Cooper, J. Org. Chem. 73, 3885 (2008)
F.A. Bassyouni, H.A. Tawfik, A.-M. Soliman, M.-A. Rehim, Res. Chem. Intermed. 38, 1291 (2012)
O.A. Fathhalla, M.S. Mohamed, M.A. Farag, R.-S. Ahmed Ismail, Res. Chem. Intermed. 39, 3487 (2013)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsai, CH., Lin, CH., Hsieh, CT. et al. Synthesis and biological evaluation of peptidyl organotrifluoroborates and their corresponding boron analogs. Res Chem Intermed 40, 2187–2198 (2014). https://doi.org/10.1007/s11164-014-1596-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-014-1596-7